Novo Nordisk reported 12.78 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Bausch Health Companies 6.98 0.41 Dec/2025
Bristol-Myers Squibb 9.08 0.2 Mar/2026
Eli Lilly 40.27 0.06 Mar/2026
GlaxoSmithKline 14.87 3.72 Mar/2026
Merck 16.52 2.6 Mar/2026
Novartis 20.17 2.32 Mar/2026
Novo Nordisk 12.78 0.01 Dec/2025
Novo Nordisk 13.92 4.91 Sep/2025
Pacira 38.58 14.1 Mar/2026
Sanofi 11.84 0.14 Mar/2026
Supernus Pharmaceuticals 44.21 66.17 Mar/2026